William Wood

In Practice

A physician’s view of the challenges and rewards of patient care.

In Practice

The Handoff: Transferring CAR T Patients Back to the Community Setting

Cell Therapy Next, May 2019
Julio C. Chavez, MD
In this installment of In Practice, Julio C. Chavez, MD, assistant member in the lymphoma section of the department of malignant hematology at…
In Practice

Treatment Toxicities: Present, but Manageable

Cell Therapy Next, April 2019
Frederick L. Locke, MD
In this installment of In Practice, Frederick L. Locke, MD, Co-Leader of the Immunology Program and Director of the Immune Cell Therapy Program at…
In Practice

Patient Selection: The Key First Step to Successful CAR T-cell Therapy

Cell Therapy Next, December 2018
In the In Practice column, Cell Therapy Next will work with members of the Peer Perspective Board to break down the practical knowledge needed to…
In Practice

The denominator problem in clinical oncology

HemOnc Today, June 25, 2016
William Wood, MD
I have a fairly typical academic oncology practice. As a bone marrow transplant physician, I primarily see patients who have acute or chronic…
In Practice

Shooting for the moon: Reasons for optimism in oncology practice

HemOnc Today, May 25, 2016
William Wood, MD
In his State of the Union Address in January, President Barack Obama unveiled plans for a “moonshot” to cure cancer and empowered Vice
In PracticePublication Exclusive

State of the science: High-priority transplant trials for nonmalignant disease

HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD
Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow…
In PracticePublication Exclusive

State of the science: High-priority transplant trials for lymphoma

HemOnc Today, December 10, 2014
Hemant Murthy, MD; William Wood, MD
In the June 10 issue of HemOnc Today, we launched a series of columns to discuss high-priority proposals that emerged from the 2014 Blood and Marrow…
In PracticePublication Exclusive

State of the science: High-priority transplant trials for AML, MDS

HemOnc Today, August 10, 2014
William Wood, MD
In my June 10 column in HemOnc Today, I introduced a series of articles about contemporary clinical challenges and research priorities in the field…
In Practice

The state of the science: Starting a dialogue about HSCT

HemOnc Today, June 10, 2014
William Wood, MD
In 2013, Science magazine designated cancer immunotherapy as its breakthrough of the year.
In Practice

Online chats allow patients, physicians and advocates to share insights, experiences

HemOnc Today, November 25, 2013
William Wood, MD
I have written previously about the ability of Twitter to facilitate conversations around topics relevant to hematology and oncology. I recently…